Literature DB >> 16261827

Pulmonary arterial disease in cats seropositive for Dirofilaria immitis but lacking adult heartworms in the heart and lungs.

Leanne E Browne1, Todd D Carter, Julie K Levy, Patti S Snyder, Calvin M Johnson.   

Abstract

OBJECTIVE: To determine the prevalence and severity of pulmonary arterial lesions in cats seropositive for heartworms (Dirofilaria immitis) but lacking adult heartworms in the heart and lungs during necropsy. ANIMALS: 630 adult cats from an animal control shelter in Florida. PROCEDURE: Cats were tested for adult heartworms in the heart and pulmonary arteries and antibody against heartworms in the serum. Histologic examination was conducted on the right caudal lung lobe of 24 heartworm- and antibody-positive cats; 24 heartworm-negative and antibody-positive cats; and 24 heartworm-, antibody-, and antigen-negative cats. Wall areas of 10 small to medium-sized pulmonary arteries of each cat were measured and expressed as a proportion of total cross-sectional area.
RESULTS: Heartworm infection or seropositive status was significantly and strongly associated with seventy of medial hypertrophy of pulmonary arterial walls. Heartworm- and antibody-positive cats and heartworm-negative and antibody-positive cats had a significant increase in wall thickness, compared with wall thickness for heartworm- and antibody-negative cats. Heartworm- and antibody-positive cats had the most severe hypertrophy. The proportion with occlusive medial hypertrophy was significantly higher in heartworm- and antibody-positive cats (19/24 [79%]) and heartworm-negative and antibody-positive cats (12/24 [50%]), compared with heartworm- and antibody-negative cats (3/24 [13%]). CONCLUSIONS AND CLINICAL RELEVANCE: Cats with serologic evidence of exposure to heartworms, including those without adult heartworms in the lungs and heart, have a greater prevalence of pulmonary arterial lesions than heartworm-negative cats without serologic evidence of exposure. Additional studies are needed to define the pathogenesis, specificity, and clinical importance of these lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16261827     DOI: 10.2460/ajvr.2005.66.1544

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  9 in total

1.  Detection of Wolbachia DNA in blood for diagnosing filaria-associated syndromes in cats.

Authors:  Maria Elena Turba; Elisa Zambon; Augusta Zannoni; Samanta Russo; Fabio Gentilini
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

Review 2.  Human and animal dirofilariasis: the emergence of a zoonotic mosaic.

Authors:  Fernando Simón; Mar Siles-Lucas; Rodrigo Morchón; Javier González-Miguel; Isabel Mellado; Elena Carretón; Jose Alberto Montoya-Alonso
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Moxidectin steady state prior to inoculation protects cats from subsequent, repeated infection with Dirofilaria immitis.

Authors:  Susan E Little; Joe A Hostetler; Jennifer E Thomas; Keith L Bailey; Anne W Barrett; Kaylynn Gruntmeir; Jeff Gruntmeir; Lindsay A Starkey; Chris Basel; Byron L Blagburn
Journal:  Parasit Vectors       Date:  2015-02-18       Impact factor: 3.876

4.  Heartworm-associated respiratory disease (HARD) induced by immature adult Dirofilaria immitis in cats.

Authors:  A Ray Dillon; Byron L Blagburn; Michael Tillson; William Brawner; Betsy Welles; Calvin Johnson; Russell Cattley; Pat Rynders; Sharron Barney
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

5.  The progression of heartworm associated respiratory disease (HARD) in SPF cats 18 months after Dirofilaria immitis infection.

Authors:  A Ray Dillon; Bryon L Blagburn; Michael Tillson; William Brawner; Betsy Welles; Calvin Johnson; Russell Cattley; Pat Rynders; Sharron Barney
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

6.  Intestinal parasites and vector-borne pathogens in stray and free-roaming cats living in continental and insular Greece.

Authors:  Anastasia Diakou; Angela Di Cesare; Paolo Matteo Accettura; Luciano Barros; Raffaella Iorio; Barbara Paoletti; Antonio Frangipane di Regalbono; Lénaïg Halos; Frederic Beugnet; Donato Traversa
Journal:  PLoS Negl Trop Dis       Date:  2017-01-31

7.  Prevalence of heartworm infection in the feral cat population of Grand Cayman.

Authors:  Brandy Darby; Charles Dickinson; Lori Gaskins; Paul Hanna
Journal:  JFMS Open Rep       Date:  2019-03-26

8.  Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for the prevention of heartworm disease in cats.

Authors:  Christine Baker; John McCall; Abdelmoneim Mansour; Scott McCall; Tayna Shaffer; Kenneth Wakeland; Elizabeth Mitchell; Justin Frost; Eric Tielemans; Dwight Bowman
Journal:  Parasite       Date:  2021-04-02       Impact factor: 3.000

9.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.